Turn Therapeutics Inc.

NASDAQ:TTRX

Biotechnology

Healthcare
$8.64 -2.79%

-$0.17 today

Market cap
$264.15M
Beta
2.77
P/E (TTM)
-45.0
EPS (TTM)
-$0.13
52W Low $2.57High $26.50

Volume 0.13M

Average 0.04M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$5.86M

FY 2025 · Annual

Net Income

-$3.19M

FY 2025 · Annual

Income Statement

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue000
Cost of Revenue000
Gross Profit000
Gross Margin———
Research & Development7.5K245.96K265.57K
Selling, General & Admin2.3M1.55M5.59M
Operating Expenses2.31M1.8M5.86M
Depreciation & Amortization43.92K47.48K52.75K
EBITDA(2.25M)(1.72M)(3.14M)
EBITDA Margin———
Operating Income(2.31M)(1.8M)(5.86M)
Operating Margin———
Interest Income15.88K28.71K29.58K
Interest Expense000
Other Income / Expenses15.88K28.71K2.66M
Income Before Tax(2.29M)(1.77M)(3.19M)
Pre-Tax Margin———
Income Tax Expense000
Net Income(2.29M)(1.77M)(3.19M)
Net Margin———
EPS (Basic)(0.17)(0.13)(0.23)
EPS (Diluted)(0.17)(0.13)(0.23)
Weighted Avg Shares13.25M13.42M13.74M
Weighted Avg Shares (Diluted)13.25M13.42M13.74M

TTRX Earnings Waterfall · TTM

NASDAQ:TTRX · Revenue to Net Income

Key Ratios

EPS$-0.18
Gross Margin0.0%
Net Margin0.0%
P/E Ratio8.6
P/S Ratio0.0

Analysis

$0 of revenue converted into -$3.8M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.18, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
S-3S-3 filingNov 9, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
S-3S-3 filingNov 9, 2026

How much revenue does TTRX generate?

Turn Therapeutics Inc. (TTRX) reported $0.00 of revenue in fiscal 2025.

Is TTRX profitable?

Turn Therapeutics Inc. (TTRX) reported -$3.19M of net income.